Searched for
BULK DRUG IMPORTS
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- India attracted $843 billion in FDI between 2014-15 and 2025-26: OfficialIndia has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- India following diversified strategy to boost exports to China, cut import dependence: OfficialIndia is pursuing a multi-pronged approach to boost its exports to China. The nation is focusing on building its own industrial capabilitie...
- India still heavily reliant on China for life saving drugs despite PLI booster: ReportIndia's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, accor...
- China accounted for around 67 per cent of India's bulk drug imports in FY19As India is a signatory to the WTO and TRIPs agreement, as such the import restrictions have been removed," Gowda said.
- China accounts for 66% of India's bulk drug imports in FY'17"The imports are mainly done for economic consideration and there are various manufacturers who could substitute in case of interrupted sup...
- India developing bulk drugs to reduce import dependenceThe country's import of active pharmaceutical ingredients (APIs) from China is high but there is enough capacity for domestic production, s...
- China accounts for 66 per cent of India's bulk drug imports in FY'17India's import of active pharmaceutical ingredients (API) from China stood at Rs 12,254.97 crore in 2016-17, while that from the US was at ...
- Government working on recommendations to reduce bulk drug importsAhir was speaking on the sidelines of 13th Pharmaceutical Conclave organised by industry body CII in partnership with Department of Pharmac...
- Govt working on policy to raise bulk drugs outputThe government is working on a policy to raise the domestic output of bulk drugs and bring down imports.
- India will be self-reliant in bulk drugs by 2020: GovernmentUnion Minister Ananth Kumar today said the country will be self-reliant in bulk drug in the next five years.
- PMO to review the status of bulk drug imports todayThe Prime Minister's Office has called a meeting on Thursday to review the status of imports of bulk drugs, also known as active pharmaceut...
- Need to reduce dependence on bulk drug imports from China: V K SubburajSubburaj said: "Pharma sector has grown well in our country. It is in the sector of bulk drugs where we are dependent on imports."
- India to tighten scrutiny on bulk drug imports from ChinaIndian authorities will tighten their vigil on bulk drug imports from China after cancelling registrations from ten Chinese companies last ...
- Indian team to do quality check at Chinese drug cosThe health ministry is planning to send a team of drug inspectors to China to inspect drug manufacturing facilities that supply bulk drugs ...
- Pharma ministry asks NPPA to clear price change applications in 30 daysThe department of pharmaceuticals has asked the National Pharmaceutical Pricing Authority (NPPA) to clear price revision applications recei...
- Drug cos catch cold as raw material costs riseEscalating cost of raw materials has pushed Indian drugmakers to a corner. While the prices of bulk drugs imported from China have increase...
Load More
